Search alternatives:
de decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 de » 2 d (Expand Search), _ de (Expand Search), i de (Expand Search)
de decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 de » 2 d (Expand Search), _ de (Expand Search), i de (Expand Search)
-
1941
-
1942
-
1943
Results for K<sub>s</sub>/D = 8.8 × 10<sup>−5</sup>, (a) Power, (b) Frequency, and (c) Amplitude.
Published 2025Subjects: -
1944
Results for K<sub>s</sub>/D = 5.08 × 10<sup>−4</sup>, (a) Power, (b) Frequency, and (c) Amplitude.
Published 2025Subjects: -
1945
S5 Fig -
Published 2024“…Cost-based pricing models are discussed as a possibility for cost containment. This study focuses on two drugs, pembrolizumab (Keytruda) and daratumumab (Darzalex), to explore the potential effect of indication broadening on the estimated price when using the cost-based pricing (CBP) model proposed by Uyl-de Groot and Löwenberg (2018).…”
-
1946
-
1947
-
1948
-
1949
-
1950
-
1951
-
1952
-
1953
-
1954
-
1955
-
1956
-
1957
-
1958
-
1959
-
1960